Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.40 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.40 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14176574 | 0.87 | DHODH (0.38) | GAALMNAALDH1A1PKMCFTR | |
| SCHEMBL14423097 | 0.87 | SLC16A3 (0.49) | GAALMNAALDH1A1MAPTMAPK1 | |
| SCHEMBL272686 | 0.87 | KMT2A (0.47) | GAALMNAALDH1A1PKMCFTR | |
| SCHEMBL272581 | 0.86 | SMN1; SMN2 (0.49) | GAALMNAKCNK3KCNK9MAPT | |
| SCHEMBL4831516 | 0.86 | SMN1; SMN2 (0.51) | GAALMNAALDH1A1RXFP1KMT2A | |
| SCHEMBL4827248 | 0.86 | HPGD (0.56) | LMNAALDH1A1RXFP1NPC1HTT | |
| SCHEMBL14523918 | 0.84 | LMNA (0.45) | GAALMNAALDH1A1PKMCFTR | |
| SCHEMBL274896 | 0.83 | ATM (0.43) | — | |
| SCHEMBL5985534 | 0.82 | MDM4 (0.50) | GAALMNAALDH1A1KCNK3KCNK9 | |
| SCHEMBL13295653 | 0.81 | ATM (0.44) | GAALMNAMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070082877-A1 | Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof | BAYER CORPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070082877-A1 | Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof | BAYER CORPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070082877-A1 | Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof | BAYER CORPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082877-A1 | Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof | FBL, Q6ZSR9, DDT | GAA 466/4885LMNA 4195/4885ALDH1A1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.